Hap Trading, LLC Glycomimetics Inc Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$1.0 - $1.58 $36,200 - $57,196	-36,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.44 - $2.14 $4,176 - $6,206	2,900 Added 8.71%	36,200 $1,000
Q3 2021 Nov 10, 2021	BUY	$1.8 - $2.39 $40,680 - $54,014	22,600 Added 211.21%	33,300 $7,000
Q2 2021 Aug 11, 2021	BUY	$2.16 - $3.18 $23,112 - $34,026	10,700 New	10,700 $2,000

36.8M

969K

636K

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $14.7M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.